TITLE

Significant differences in the material properties between aged human and porcine aortic tissues

AUTHOR(S)
Martin, Caitlin; Pham, Thuy; Sun, Wei
PUB. DATE
July 2011
SOURCE
European Journal of Cardio-Thoracic Surgery;Jul2011, Vol. 40 Issue 1, p28
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract: Objective: Currently, percutaneous aortic valve (PAV) replacement devices are being investigated to treat aortic stenosis in patients deemed to be of too high a risk for conventional open-chest surgery. Successful PAV deployment and function are heavily reliant on the tissue–stent interaction. Many PAV feasibility trials have been conducted with porcine models under the assumption that these tissues are similar to human; however, this assumption may not be valid. The goal of this study was to characterize and compare the biomechanical properties of aged human and porcine aortic tissues. Methods: The biaxial mechanical properties of the left coronary sinus, right coronary sinus, non-coronary sinus, and ascending aorta of eight aged human (90.1±6.8 years) and 10 porcine (6–9 months) hearts were quantified. Tissue structure was analyzed via histological techniques. Results: Aged human aortic tissues were significantly stiffer than the corresponding porcine tissues in both the circumferential and longitudinal directions (p <0.001). In addition, the nearly linear stress–strain behavior of the porcine tissues, compared with the highly nonlinear response of the human tissues at a low strain range, suggested structural differences between the aortic tissues from these two species. Histological analysis revealed that porcine samples were composed of more elastin and less collagen fibers than the respective human samples. Conclusions: Significant material and structural differences were observed between the human and porcine tissues, which raise questions on the validity of using porcine models to investigate the biomechanics involved in PAV intervention.
ACCESSION #
61175244

 

Related Articles

  • Heartbeat: Highlights from this issue. Otto, Catherine M. // Heart;Oct2014, Vol. 100 Issue 20, p1563 

    An introduction is presented in which the editor discusses various research articles within the issue on topics including aortic valve replacement in patients with severe symptomatic aortic stenosis (AS), clinical factors in coronary disease events and clinical guidelines in daily practice.

  • Transcatheter Aortic Valve Replacement: A Physician-Patient's Story. Fred, Herbert L. // Texas Heart Institute Journal;Aug2015, Vol. 42 Issue 4, p305 

    A personal narrative is presented which explores the author's experiences as a physician undergoing transcatheter aortic valve replacement to treat his aortic stenosis.

  • Percutaneous Transcatheter Aortic Valve Implantation: A Review Focus on Outcomes and Safety. Ortega-Paz, Luis; Giacchi, Giuseppe; Brugaletta, Salvatore; Sabaté, Manel // AIMS Medical Science;Jul2015, Vol. 2 Issue 3, p200 

    Aortic stenosis is highly prevalent in the elderly, when symptomatic, is associated with high mortality. Although its treatment is mainly surgical, cumulative evidence has demonstrated that transcatheter aortic valve implantation is an effective and safe treatment option for selected patients,...

  • "Valve in valve" transcutaneous aortic valve repair for severe paravalvular leak: a case presentation and literature review. Linte, Adrian; Căldăraru, Cristina; Constantinescu, Dana; Popa, Călin; Cebotaru, Theodor; Şteiu, Flaviu; Alexandrescu, Maria; Fruntelată, Ana; Bălănescu, Şerban // Romanian Journal of Cardiology;2014, Vol. 24 Issue 1, p34 

    Surgical replacement of the native aortic valve with either a biological or a mechanical valve has been the "gold standard" treatment for severe symptomatic aortic stenosis for a long time. However, during the last ten years transcutaneous aortic valve replacement (TAVR) has emerged as an...

  • BNP during exercise: a novel use for a familiar biomarker in aortic stenosis. Lindman, Brian R. // Heart;Oct2014, Vol. 100 Issue 20, p1567 

    The author looks at a research related to significance of aortic valve replacement (AVR) to a patient with severe aortic stenosis (AS). Topics discussed include recommendation for AVR in those with asymptomatic severe AS, evaluation of B-type natriuretic peptide (BNP) level and development of...

  • Sorin Group Announces First Implant in U.S. Study of Stentless Pericardial Aortic Valve.  // Biomedical Market Newsletter;2/21/2012, Vol. 21, p1 

    The article informs that the company Sorin Group has announced initiation of a U.S. investigational device exemption (IDE) study for its Freedom Solo Stentless (FSS) Pericardial aortic valve. The study trial has been designed to evaluate the safety and effectiveness of the FSS valve for patients...

  • Editorial Comment: Pericardial traumatic injury in trans-catheter aortic valve implantation. Barbera, Mila Della; Valente, Marialuisa; Basso, Cristina; Thiene, Gaetano // European Journal of Cardio-Thoracic Surgery;Mar2013, Vol. 43 Issue 3, p493 

    The authors reflect on the transcatheter aortic valve implantation (TAVI) for treating native aortic stenosis or failed bioprostheses. They mention TAVI requires cusp crimping to treat the cusp injury associated with the percutaneous aortic valve deployment of the medical device Edwards Sapien...

  • Transcatheter Aortic Valve Replacement: Important Considerations. Hitt, Emma // MD Conference Express;Aug2013, Vol. 13 Issue 7, p24 

    Although surgical aortic valve replacement is recommended by clinical practice guidelines in patients with severe aortic stenosis, many patients with calcific aortic stenosis are not optimal candidates for surgery due to their medical comorbidities. Transcatheter aortic valve replacement (TAVR)...

  • Adiponectin: an accurate biomarker for patients at risk for atrial fibrillation? Ruparelia, Neil; Prendergast, Bernard D. // Heart;Sep2015, Vol. 101 Issue 17, p1351 

    The article focuses on a study on treatment of aortic stenosis (AS) by transcatheter aortic valve implantation (TAVI). Topics discussed include testing efficacy of TAVI by placement of aortic transcatheter valves (PARTNER) I trial, techniques used for evaluating aortic valve function such as...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics